Blog

Blinding in Clinical Trials

Chief Pharmacist

A procedure in which one or more parties to the trial are kept unaware of the treatment assignment(s). Single-blinding usually ...

Bridging Study

Chief Pharmacist

A bridging study is defined as a supplemental study performed in the new region to provide pharmacodynamic or clinical data ...

Business Case

Chief Pharmacist

The reason for making an investment (in whatever form), performing a process or using a tool. It often includes economic ...

Blending in Pharmaceutical Manufacturing

Chief Pharmacist

Blending is defined as the process of combining materials within the same specification to produce a homogeneous intermediate or API. ...

Batch and Batch Number

Chief Pharmacist

Batch A defined quantity of starting material, packaging material or finished pharmaceutical product processed in a single process or series ...

Bracketing

Chief Pharmacist

The design of a stability schedule such that only samples on the extremes of certain design factors, e.g., strength, package ...

GxP Topics

Chief Pharmacist

GxP refers to the guidelines for Good Practice in pharmaceutical industry for ensuring safety and efficacy of products. GxP compliance ...

Orange Book

Chief Pharmacist

The Orange Book contains Approved Drug Products With Therapeutic Equivalence Evaluations, identifies drug products approved on the basis of safety ...

Drug Discovery

Chief Pharmacist

Drug discovery is the process by which new candidate medications are discovered and involves a comprehensive scientific and research-based approach ...

Generic Drug

Chief Pharmacist

Generic drugs are similar to brand-name drugs (RLD/RS). They have the same active ingredients and similar efficacy. The regulatory body ...